HIF1A and ulcerative colitis: Elevated expression levels of HIF-1α were evidenced in patients with Crohn’s disease and ulcerative colitis, indicating its protective role in mitigating inflammatory bowel disorders by improving the epithelial barrier functionality (Shah, 2016).